Scarica l'app Stockscreener
347.94
1.51%
-5.34
Dopo l'orario di chiusura:
347.78
-0.16
-0.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 Sh Trade Ideas — BMFBOVESPA:AMGN34 - TradingView
Amgen Inc. $AMGN Position Boosted by JB Capital LLC - MarketBeat
A Look At Amgen (AMGN) Valuation After New Repatha Data And Zai Lab Oncology Collaboration - simplywall.st
Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer - BioPharma APAC
Thurston Springer Miller Herd & Titak Inc. Acquires 3,354 Shares of Amgen Inc. $AMGN - MarketBeat
SteelPeak Wealth LLC Has $37.88 Million Holdings in Amgen Inc. $AMGN - MarketBeat
AbbVie & Amgen: Safe Dividend Stocks for Recession Fears | 2026News and Statistics - IndexBox
Amgen Beats Estimates by $400 Million in Q4: Here’s Why Analysts Target $350 - TIKR.com
Amgen Expands Thyroid Eye Disease Bet With New AMG 732 Rollover Study - TipRanks
Dorato Capital Management Invests $1.58 Million in Amgen Inc. $AMGN - MarketBeat
Aberdeen Group plc Acquires 27,107 Shares of Amgen Inc. $AMGN - MarketBeat
How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen’s (AMGN) Risk‑Reward Profile - finance.yahoo.com
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Australia
Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory - The Motley Fool
Amgen's Diversification Continues To Pay Off, RBC Says - Moomoo
Turning Up the Volume on IgG4-RD Awareness and Diagnosis - Amgen
Amgen Terminates Early-Stage AMG 378 Study: What Investors Should Watch Next - tipranks.com
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now? - finance.yahoo.com
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $390 - Moomoo
HF Advisory Group LLC Buys 7,548 Shares of Amgen Inc. $AMGN - MarketBeat
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 - GlobeNewswire
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate - finance.yahoo.com
Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: ReportAmgen (NASDAQ:AM - Benzinga
Zai Lab (09688.HK) Enters Global Collaboration with Amgen (AMGN.US) to Explore Novel ADC and BiTE Combination Therapy - AASTOCKS.com
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Will FDA Tavneos Safety Scrutiny and New Lung Cancer Combo Trial Change Amgen's (AMGN) Narrative? - simplywall.st
AMGEN INC (AMGNCL.SN) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Amgen Inc. Stock: Biotech Leader's Strategic Pipeline and Oncology Focus Drive Long-Term Investor Va - AD HOC NEWS
Zai Lab gains after Amgen clinical trial deal (ZLAB:NASDAQ) - Seeking Alpha
Here's What You Need to Know about Amgen, Inc's AMG-145 - Yahoo
Amgen (AMGN) and Zai Lab Partner for Lung Cancer Treatment Study - gurufocus.com
Once the center of a $3.7 billion buyout, drug blamed for eight deaths draws FDA alert - The Business Journals
Zai Lab Limited and Amgen Inc Enter Global Clinical Trial Collaboration Agreement - MarketScreener
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $432 - Moomoo
A two-drug small cell lung cancer trial pairs Amgen with Zai Lab - Stock Titan
Highline Wealth Partners LLC Sells 4,004 Shares of Amgen Inc. $AMGN - MarketBeat
Nisa Investment Advisors LLC Has $55.22 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat
Amgen Inc. $AMGN Shares Bought by Moody Lynn & Lieberson LLC - MarketBeat
Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN
Amgen Inc. (0R0T.IL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Sarcopenia Treatments Market Is Going to Boom | AbbVie • Amgen • Pfizer • Novartis - openpr.com
BTC Capital Management Inc. Sells 4,196 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Given Average Rating of "Hold" by Analysts - MarketBeat
FDA Says Amgen’s Tavneos Linked to Liver Injuries, Deaths - wsj.com
US FDA warns of liver injury cases tied to Amgen's rare disease drug - Reuters
FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos UseAmgen (NASDAQ:AMGN) - Benzinga
FDA Flags Serious Liver Risks with Amgen's Tavneos (AMGN) - GuruFocus
FDA issues warning for Amgen's Tavneos following serious liver injury cases - Seeking Alpha
Amgen CEO Bob Bradway's 2025 Letter to Shareholders - Amgen
Amgen’s Tavneos Associated With Liver Injury, Deaths, FDA Says - Bloomberg.com
Amgen price breaches upside trend lineForecast tody31-03-2026 - Economies.com
Amgen Inc. $AMGN Shares Purchased by Hofer & Associates. Inc - MarketBeat
The Zacks Analyst Blog Roche Holding, AT&T and Amgen - The Globe and Mail
Mn Services Vermogensbeheer B.V. Acquires 3,327 Shares of Amgen Inc. $AMGN - MarketBeat
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN - MarketBeat
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN - MarketBeat
Top Stock Reports for Roche, AT&T & Amgen - The Globe and Mail
Jefferies reiterates Amgen stock Hold rating on TED trial data - Investing.com
Amgen (AMGN) stock up since Jim Cramer said "You could do a lot worse than Amgen" - MSN
Amgen Inc. Stock: Steady Biotech Leader with Strong Dividend Yield and Growth Guidance Amid Analyst - AD HOC NEWS
Amgen’s Repatha Slashes Heart Event Risk in Early‑Stage Patients - Citeline News & Insights
0.42%
1.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):